Challenges in liver cancer and possible treatment approaches

By David Anwanwan, S. K. Singh, Shriti Singh, Varma Saikam, Rajesh Singh. Biochimica et biophysica acta. Reviews on cancer, 2019

1,317 citations recorded by the source corpus.

Globally, liver cancer is the most frequent fatal malignancy; in the United States, it ranks fifth. Patients are often diagnosed with liver cancer in advanced stages, contributing to its poor prognosis. Of all liver cancer cases, >90% are hepatocellular carcinomas (HCCs) for which chemotherapy and immunotherapy are the best options for therapy. For liver cancer patients, new treatment options are necessary. Use of natural compounds and/or nanotechnology may provide patients with better outcomes with lower systemic toxicity and fewer side effects. Improved treatments can lead to better prognoses. Finally, in this review, we present some of the problems and current treatment options contributing to the poor outcomes for patients with liver cancer.

Subfields: Epidemiology, Hepatology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/8905d73ea68d3ab7e5c21d90e64aa1c36bca047e